Scientists at the Broad Institute and Mass General Brigham have built a generative AI model that creates short DNA segments that can control gene activity in specific cells. These sequences, called cis-regulatory elements (CREs), make up a large part of the human genome, and synthetic versions of these bits of DNA could one day be part of gene therapies that tune gene activity to treat disease.